← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2012Last known activity
Jun 12, 2024
Timeline
2010s
- Jun 1, 2010
Delta-Fly Pharma, Inc.— Founded
Drugs by trial phase (12 distinct, 6 trials)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT06382168Lead sponsorPhase 1/Phase 2Jun 12, 2024
- NCT03943004Lead sponsorPhase 1Jul 1, 2019
- NCT03926624Lead sponsorPhase 3Apr 30, 2019
- NCT02646852Lead sponsorPhase 1Mar 1, 2016
- NCT02171221Lead sponsorPhase 1Jun 1, 2014
- NCT01702155Lead sponsorPhase 1/Phase 2Sep 1, 2012
Details
- Founded
- Tokushima, JP Jun 1, 2010
- Last known activity
- Jun 12, 2024